23 Feb Poseida Therapeutics
Matthew Spear, M.D., Chief Medical Officer
Oct. 13 | 5:30pm | AVROBIO Ballroom
San Diego, CA
Poseida Therapeutics is a clinical-stage biopharmaceutical company leveraging proprietary next-generation, non-viral gene engineering technologies to create ground-breaking, life-saving cell and gene therapies for patients with high unmet medical need. At Poseida, we are using our broad gene engineering platform technologies to bring new and better treatments to patients with serious diseases – blood cancers like multiple myeloma, solid tumor cancers like prostate and breast cancer, and rare genetic diseases in the liver.